Vildagliptin, a novel dipeptidyl peptidase IV inhibitor, has no pharmacokinetic interactions with the antihypertensive agents amlodipine, valsartan, and ramipril in healthy subjects (Q46912016)
Jump to navigation
Jump to search
scientific article published on 6 November 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Vildagliptin, a novel dipeptidyl peptidase IV inhibitor, has no pharmacokinetic interactions with the antihypertensive agents amlodipine, valsartan, and ramipril in healthy subjects |
scientific article published on 6 November 2007 |
Statements
1 reference
Vildagliptin, a novel dipeptidyl peptidase IV inhibitor, has no pharmacokinetic interactions with the antihypertensive agents amlodipine, valsartan, and ramipril in healthy subjects (English)
1 reference
Yan-Ling He
1 reference
Monica Ligueros-Saylan
1 reference
Gangadhar Sunkara
1 reference
Ron Sabo
1 reference
Charlie Zhao
1 reference
Yibin Wang
1 reference
Joelle Campestrini
1 reference
Francoise Pommier
1 reference
Kiran Dole
1 reference
Alan Marion
1 reference
William P Dole
1 reference
Dan Howard
1 reference
6 November 2007
1 reference
48
1 reference
1
1 reference
85-95
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference